271 related articles for article (PubMed ID: 30914310)
21. Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
Xiaochuan L; Jiangyong Y; Ping Z; Xiaonan W; Lin L
Thorac Cancer; 2020 Jun; 11(6):1522-1532. PubMed ID: 32301286
[TBL] [Abstract][Full Text] [Related]
22. Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
Tamjid B; Phan P; John T; Mitchell P; Gan H
Head Neck; 2017 Aug; 39(8):1544-1549. PubMed ID: 28593651
[TBL] [Abstract][Full Text] [Related]
23. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
[TBL] [Abstract][Full Text] [Related]
24. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
25. Survival After Distant Metastasis in Head and Neck Cancer.
Wiegand S; Zimmermann A; Wilhelm T; Werner JA
Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
[TBL] [Abstract][Full Text] [Related]
26. Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis.
Chen Z; Yin K; Zheng D; Gu J; Luo J; Wang S; Chen H
J Cancer Res Clin Oncol; 2020 Jan; 146(1):67-74. PubMed ID: 31786738
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.
Rahouma M; Kamel M; Narula N; Nasar A; Harrison S; Lee B; Stiles B; Altorki NK; Port JL
Eur J Cardiothorac Surg; 2018 Apr; 53(4):828-834. PubMed ID: 29240878
[TBL] [Abstract][Full Text] [Related]
28. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.
Steuer CE; Behera M; Kim S; Chen Z; Saba NF; Pillai RN; Owonikoko TK; Khuri FR; Ramalingam SS
J Thorac Oncol; 2015 Mar; 10(3):479-85. PubMed ID: 25371080
[TBL] [Abstract][Full Text] [Related]
29. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
30. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
31. Does intensive follow-up alter outcome in patients with advanced lung cancer?
Benamore R; Shepherd FA; Leighl N; Pintilie M; Patel M; Feld R; Herman S
J Thorac Oncol; 2007 Apr; 2(4):273-81. PubMed ID: 17409797
[TBL] [Abstract][Full Text] [Related]
32. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
[TBL] [Abstract][Full Text] [Related]
34. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
36. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
Shi S; Xie H; Yin W; Zhang Y; Peng X; Yu F; Shemanski KA; Kim AW; Wang X
J Surg Oncol; 2020 Jun; 121(8):1233-1240. PubMed ID: 32170977
[TBL] [Abstract][Full Text] [Related]
38. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
[TBL] [Abstract][Full Text] [Related]
39. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
[TBL] [Abstract][Full Text] [Related]
40. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
